Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice.

Deutsch U, Schlaeger TM, Dehouck B, Döring A, Tauber S, Risau W, Engelhardt B.

Exp Cell Res. 2008 Apr 1;314(6):1202-16. doi: 10.1016/j.yexcr.2007.12.026. Epub 2008 Jan 15.

PMID:
18272150
2.

Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens.

Mitchell CA, Rutland CS, Walker M, Nasir M, Foss AJ, Stewart C, Gerhardt H, Konerding MA, Risau W, Drexler HC.

Angiogenesis. 2006;9(4):209-24. Epub 2006 Nov 16.

PMID:
17109192
3.

Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts.

Hamm S, Dehouck B, Kraus J, Wolburg-Buchholz K, Wolburg H, Risau W, Cecchelli R, Engelhardt B, Dehouck MP.

Cell Tissue Res. 2004 Feb;315(2):157-66. Epub 2003 Nov 13.

PMID:
14615934
4.

Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.

Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B.

Acta Neuropathol. 2003 Jun;105(6):586-92. Epub 2003 Feb 25.

PMID:
12734665
5.

Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation.

Damert A, Miquerol L, Gertsenstein M, Risau W, Nagy A.

Development. 2002 Apr;129(8):1881-92.

6.

Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.

Breier G, Blum S, Peli J, Groot M, Wild C, Risau W, Reichmann E.

Int J Cancer. 2002 Jan 10;97(2):142-8.

7.

Nucleotide sequence of the mouse VEGF 3'UTR and quantitative analysis of sites of polyadenylation.

Dibbens JA, Polyak SW, Damert A, Risau W, Vadas MA, Goodall GJ.

Biochim Biophys Acta. 2001 Mar 19;1518(1-2):57-62.

PMID:
11267659
8.

A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.

Clauss M, Sunderkötter C, Sveinbjörnsson B, Hippenstiel S, Willuweit A, Marino M, Haas E, Seljelid R, Scheurich P, Suttorp N, Grell M, Risau W.

Blood. 2001 Mar 1;97(5):1321-9.

PMID:
11222376
9.

Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.

Stratmann A, Acker T, Burger AM, Amann K, Risau W, Plate KH.

Int J Cancer. 2001 Feb 1;91(3):273-82.

10.

Endothelium-specific replacement of the connexin43 coding region by a lacZ reporter gene.

Theis M, de Wit C, Schlaeger TM, Eckardt D, Krüger O, Döring B, Risau W, Deutsch U, Pohl U, Willecke K.

Genesis. 2001 Jan;29(1):1-13.

PMID:
11135457
11.

Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development.

Kappel A, Schlaeger TM, Flamme I, Orkin SH, Risau W, Breier G.

Blood. 2000 Nov 1;96(9):3078-85.

PMID:
11049987
12.

Disruption of epithelial tight junctions is prevented by cyclic nucleotide-dependent protein kinase inhibitors.

Klingler C, Kniesel U, Bamforth SD, Wolburg H, Engelhardt B, Risau W.

Histochem Cell Biol. 2000 May;113(5):349-61.

PMID:
10883394
13.

Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.

Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W.

Am J Pathol. 2000 Mar;156(3):965-76.

14.

Angiogenesis in ischemic disease.

Marti HH, Risau W.

Thromb Haemost. 1999 Sep;82 Suppl 1:44-52. Review.

PMID:
10695485
15.

Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells.

Drexler HC, Risau W, Konerding MA.

FASEB J. 2000 Jan;14(1):65-77.

PMID:
10627281
16.

Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas.

Sasaki M, Wizigmann-Voos S, Risau W, Plate KH.

Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):579-91.

PMID:
10571419
17.
18.

Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene.

Mühlner U, Möhle-Steinlein U, Wizigmann-Voos S, Christofori G, Risau W, Wagner EF.

Oncogene. 1999 Jul 22;18(29):4200-10.

20.

A dominant mutant of occludin disrupts tight junction structure and function.

Bamforth SD, Kniesel U, Wolburg H, Engelhardt B, Risau W.

J Cell Sci. 1999 Jun;112 ( Pt 12):1879-88.

21.
22.

Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells.

Machein MR, Kullmer J, Rönicke V, Machein U, Krieg M, Damert A, Breier G, Risau W, Plate KH.

Neuropathol Appl Neurobiol. 1999 Apr;25(2):104-12.

PMID:
10215998
23.

Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements.

Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, Goodall GJ.

Mol Biol Cell. 1999 Apr;10(4):907-19.

24.
25.

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth KP, McMahon G.

Cancer Res. 1999 Jan 1;59(1):99-106.

26.
28.
29.

Regulation of endothelial monocyte-activating polypeptide II release by apoptosis.

Knies UE, Behrensdorf HA, Mitchell CA, Deutsch U, Risau W, Drexler HC, Clauss M.

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12322-7.

30.

Differentiation of blood-brain barrier endothelial cells.

Risau W, Esser S, Engelhardt B.

Pathol Biol (Paris). 1998 Mar;46(3):171-5. Review.

PMID:
9769912
31.

The vascular endothelial growth factor mRNA contains an internal ribosome entry site.

Miller DL, Dibbens JA, Damert A, Risau W, Vadas MA, Goodall GJ.

FEBS Lett. 1998 Sep 4;434(3):417-20.

32.

Development and differentiation of endothelium.

Risau W.

Kidney Int Suppl. 1998 Sep;67:S3-6. Review.

PMID:
9736244
33.

Characterization of novel nuclear targeting and apoptosis-inducing domains in FAS associated factor 1.

Fröhlich T, Risau W, Flamme I.

J Cell Sci. 1998 Aug;111 ( Pt 16):2353-63.

34.

Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.

Esser S, Lampugnani MG, Corada M, Dejana E, Risau W.

J Cell Sci. 1998 Jul;111 ( Pt 13):1853-65.

35.

VEGF induces hyperpermeability by a direct action on endothelial cells.

Hippenstiel S, Krüll M, Ikemann A, Risau W, Clauss M, Suttorp N.

Am J Physiol. 1998 May;274(5):L678-84. doi: 10.1152/ajplung.1998.274.5.L678.

PMID:
9612282
36.

Angiopoietin-1 induces sprouting angiogenesis in vitro.

Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W.

Curr Biol. 1998 Apr 23;8(9):529-32.

37.

Angiogenesis is coming of age.

Risau W.

Circ Res. 1998 May 4;82(8):926-8. Review. No abstract available.

PMID:
9576112
38.
39.

Vascular endothelial growth factor induces endothelial fenestrations in vitro.

Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W.

J Cell Biol. 1998 Feb 23;140(4):947-59.

40.

Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells.

Kataoka H, Takakura N, Nishikawa S, Tsuchida K, Kodama H, Kunisada T, Risau W, Kita T, Nishikawa SI.

Dev Growth Differ. 1997 Dec;39(6):729-40.

PMID:
9493833
41.

Molecular mechanisms of vasculogenesis and embryonic angiogenesis.

Flamme I, Frölich T, Risau W.

J Cell Physiol. 1997 Nov;173(2):206-10. Review. No abstract available.

PMID:
9365523
43.

VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries.

Laitinen M, Zachary I, Breier G, Pakkanen T, Häkkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, Ylä-Herttuala S.

Hum Gene Ther. 1997 Oct 10;8(15):1737-44.

PMID:
9358023
44.

Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses.

Laitinen M, Pakkanen T, Donetti E, Baetta R, Luoma J, Lehtolainen P, Viita H, Agrawal R, Miyanohara A, Friedmann T, Risau W, Martin JF, Soma M, Ylä-Herttuala S.

Hum Gene Ther. 1997 Sep 20;8(14):1645-50.

PMID:
9322866
45.

Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells.

Lampugnani MG, Corada M, Andriopoulou P, Esser S, Risau W, Dejana E.

J Cell Sci. 1997 Sep;110 ( Pt 17):2065-77.

46.

Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.

Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH.

Cancer Res. 1997 Sep 1;57(17):3860-4.

47.
48.

Angiogenesis in embryos and ischemic diseases.

Breier G, Damert A, Plate KH, Risau W.

Thromb Haemost. 1997 Jul;78(1):678-83. Review.

PMID:
9198238
49.

Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system.

Sabapathy KT, Pepper MS, Kiefer F, Möhle-Steinlein U, Tacchini-Cottier F, Fetka I, Breier G, Risau W, Carmeliet P, Montesano R, Wagner EF.

J Cell Biol. 1997 May 19;137(4):953-63.

50.

Flk-1 expression defines a population of early embryonic hematopoietic precursors.

Kabrun N, Bühring HJ, Choi K, Ullrich A, Risau W, Keller G.

Development. 1997 May;124(10):2039-48.

Supplemental Content

Support Center